These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Anabolic steroids and fibrinolysis.
    Author: Lowe GD.
    Journal: Wien Med Wochenschr; 1993; 143(14-15):383-5. PubMed ID: 8256452.
    Abstract:
    Anabolic steroids increase the activity of the fibrinolytic system by reducing plasma levels of inhibitors (plasminogen activator inhibitor type I, histidine-rich glycoprotein, alpha-2-macroglobulin) and increasing plasma levels of tissue-type plasminogen activator activity, plasminogen, and plasmin activity (B beta 15-42 fragment of fibrinogen). Plasminogen activator inhibitor levels are elevated, and tissue-type plasminogen activator activity is depressed, in a variety of disease states, including premature venous or arterial thrombosis, connective tissue disorders, and cancer. Such abnormalities can be reversed by anabolic steroids. However the clinical benefits and adverse effects of such treatment remain to be established by large, randomized controlled trials.
    [Abstract] [Full Text] [Related] [New Search]